Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

AcelRx Pharmaceuticals Company Profile (NASDAQ:ACRX)

Consensus Ratings for AcelRx Pharmaceuticals (NASDAQ:ACRX) (?)
Ratings Breakdown: 7 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $17.21 (68.44% upside)

Current Analysts' Coverage Summary for AcelRx Pharmaceuticals (NASDAQ:ACRX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
6/17/2014JMP SecuritiesInitiated CoverageOutperform$14.00ViewTweet This Rating  Share This Rating on StockTwits
4/17/2014Canaccord GenuityInitiated CoverageBuy$16.00ViewTweet This Rating  Share This Rating on StockTwits
4/14/2014Roth CapitalInitiated CoverageBuy$22.00ViewTweet This Rating  Share This Rating on StockTwits
4/10/2014Jefferies GroupInitiated CoverageBuy$17.00ViewTweet This Rating  Share This Rating on StockTwits
1/6/2014RBC CapitalInitiated CoverageOutperform$15.00ViewTweet This Rating  Share This Rating on StockTwits
12/19/2013MizuhoBoost Price TargetBuy$18.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
12/17/2013MLV & Co Boost Price TargetBuy$15.00 -> $16.50ViewTweet This Rating  Share This Rating on StockTwits
5/28/2013GuggenheimBoost Price TargetBuy$7.00 -> $15.00ViewTweet This Rating  Share This Rating on StockTwits
11/15/2012Cowen and CompanyReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2012 forward)